Keyword: Sanofi


Sanofi in Lockstep with US Insulin Price Cuts

20.03.2023 -

The world's largest insulin producers, Eli Lilly, NovoNordisk and Sanofi are now marching (almost) in lockstep to reduce US market prices, but not without tossing...


Novo Nordisk to Cut US Insulin prices from 2024

16.03.2023 -

Danish drugmaker Novo Nordisk has added its name to the list of insulin producers cutting prices for US retail buyers, following up on Eli Lilly’s announcement of price...


Sanofi Buying Diabetes Specialist Provention Bio

15.03.2023 -

Paris-based French drugmaker Sanofi has agreed to acquire Provention Bio for $25 per share in cash, representing an equity value of about $2.9 billion. The publicly...


Lilly Insulin Price Cut Revives US Discussion

14.03.2023 -

As the discussion surrounding the high price of insulin in the US continues unabated, drugmaker Eli Lilly implemented price reductions of 70% for its most commonly...


Sanofi Strengthens Venture Capital Budget

19.01.2023 -

As well as serving as a financial partner to fledgling companies, the VC fund supports future efforts for business development and M&A opportunities within its own...


EuroAPI Invests €40 Million in French B12 Production

12.01.2023 -

Leading active pharmaceutical ingredients manufacturer EuroAPI plans to invest €40 million at its site in Saint-Aubin-lès-Elbeuf, France, to launch a new production...


Sanofi Enters Research Pact with Hong Kong’s Insilico

15.11.2022 -

French pharma Sanofi has entered a multi-year, multi-target research collaboration worth up to $1.2 billion with Hong Kong biotech Insilico Medicine.


EU Approves Sanofi/GSK Covid Booster

11.11.2022 -

After several delays and restarts and a lengthy review by the European Medicines Agency (EMA), the Covid-19 vaccine called VidPrevtyn Beta developed by the French-British...